HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock.

AbstractINTRODUCTION:
Septic syndromes remain the leading cause of mortality in intensive care units (ICU). Septic patients rapidly develop immune dysfunctions, the intensity and duration of which have been linked with deleterious outcomes. Decreased mRNA expressions of major histocompatibility complex (MHC) class II-related genes have been reported after sepsis. We investigated whether their mRNA levels in whole blood could predict mortality in septic shock patients.
METHODS:
A total of 93 septic shock patients were included. On the third day after shock, the mRNA expressions of five MHC class II-related genes (CD74, HLA-DRA, HLA-DMB, HLA-DMA, CIITA) were measured by qRT-PCR and monocyte human leukocyte antigen-DR (mHLA-DR) by flow cytometry.
RESULTS:
A significant correlation was found among MHC class II related gene expressions. Among mRNA markers, the best prognostic value was obtained for CD74 (HLA-DR antigen-associated invariant chain). For this parameter, the area under the receiver operating characteristic curve (AUC) was calculated (AUC = 0.67, 95% confidence interval (CI) = 0.55 to 0.79; P = 0.01) as well as the optimal cut-off value. After stratification based on this threshold, survival curves showed that a decreased CD74 mRNA level was associated with increased mortality after septic shock (Log rank test, P = 0.0043, Hazard Ratio = 3.0, 95% CI: 1.4 to 6.5). Importantly, this association remained significant after multivariate logistic regression analysis including usual clinical confounders (that is, severity scores, P = 0.026, Odds Ratio = 3.4, 95% CI: 1.2 to 9.8).
CONCLUSION:
Decreased CD74 mRNA expression significantly predicts 28-day mortality after septic shock. After validation in a larger multicentric study, this biomarker could become a robust predictor of death in septic patients.
AuthorsMarie-Angélique Cazalis, Arnaud Friggeri, Laura Cavé, Julie Demaret, Véronique Barbalat, Elisabeth Cerrato, Alain Lepape, Alexandre Pachot, Guillaume Monneret, Fabienne Venet
JournalCritical care (London, England) (Crit Care) Vol. 17 Issue 6 Pg. R287 (Dec 10 2013) ISSN: 1466-609X [Electronic] England
PMID24321376 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, B-Lymphocyte
  • Biomarkers
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II
  • RNA, Messenger
  • invariant chain
Topics
  • Aged
  • Antigens, CD (blood)
  • Antigens, Differentiation, B-Lymphocyte (blood)
  • Biomarkers (blood)
  • Female
  • HLA-DR Antigens (blood)
  • Histocompatibility Antigens Class II (blood)
  • Hospital Mortality
  • Humans
  • Male
  • Middle Aged
  • RNA, Messenger (blood)
  • Shock, Septic (blood, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: